NEVE; Soren
Patent Applications and Registrations
Patent applications and USPTO patent grants for NEVE; Soren.The latest application filed is for "enzymatic encoding methods for efficient synthesis of large libraries".
- NEVE; Soren - Lyngby DK
- NEVE; Soren - Kgs. Lyngby DK
| Patent | Date |
|---|---|
| Enzymatic Encoding Methods For Efficient Synthesis Of Large Libraries App 20200216836 - FRANCH; Thomas ; et al. | 2020-07-09 |
| Enzymatic Encoding Methods For Efficient Synthesis Of Large Libraries App 20190330618 - FRANCH; Thomas ; et al. | 2019-10-31 |
| Enzymatic encoding methods for efficient synthesis of large libraries Grant 10,287,576 - Franch , et al. | 2019-05-14 |
| Peptide Agonists Of Glp-1 Activity App 20180362611 - LARSEN; Bjarne Due ; et al. | 2018-12-20 |
| Enzymatic Encoding Methods For Efficient Synthesis Of Large Libraries App 20170247688 - FRANCH; Thomas ; et al. | 2017-08-31 |
| Peptide Agonists Of Glp-1 Activity App 20170107267 - LARSEN; Bjarne Due ; et al. | 2017-04-20 |
| Enzymatic encoding methods for efficient synthesis of large libraries Grant 9,574,189 - Franch , et al. February 21, 2 | 2017-02-21 |
| Antimicrobial Peptide Variants and Polynucleotides Encoding Same App 20160158317 - Hoegenhaug; Hans-Henrik Kristensen ; et al. | 2016-06-09 |
| Antimicrobial Peptide Variants and Polynucleotides Encoding Same App 20150031601 - Hoegenhaug; Hans-Henrik Kristensen ; et al. | 2015-01-29 |
| Exendin variant peptides Grant RE45,313 - Larsen , et al. December 30, 2 | 2014-12-30 |
| Peptide Agonists Of Glp-1 Activity App 20140336356 - LARSEN; Bjarne D. ; et al. | 2014-11-13 |
| Antimicrobial peptide variants and polynucleotides encoding same Grant 8,835,604 - Hoegenhaug , et al. September 16, 2 | 2014-09-16 |
| Methods For Using Peptide Agonists Having Glp-1 Activity App 20130210722 - LARSEN; BJARNE DUE ; et al. | 2013-08-15 |
| Antimicrobial Peptide Variants And Polynucleotides Encoding Same App 20110306750 - Hoegenhaug; Hans-Henrik Kristensen ; et al. | 2011-12-15 |
| Peptide Agonists Of Glp-1 Activity App 20110245165 - LARSEN; Bjarne Due ; et al. | 2011-10-06 |
| Peptide Agonists Of Glp-1 Activity App 20110144008 - LARSEN; Bjarne Due ; et al. | 2011-06-16 |
| Peptide agonists of GLP-1 activity App 20070111940 - Larsen; Bjarne Due ; et al. | 2007-05-17 |
| Compositions and methods for modulating connexin hemichannels App 20070042964 - Jensen; Peter Holme ; et al. | 2007-02-22 |
| Compositions and methods for modulating connexin hemichannels Grant 7,153,822 - Jensen , et al. December 26, 2 | 2006-12-26 |
| Method for obtaining structural information about an encoded molecule App 20060269920 - Freskgard; Per-Ola ; et al. | 2006-11-30 |
| Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease App 20040152868 - Larsen, Bjarne Due ; et al. | 2004-08-05 |
| Novel peptide agonists of GLP-1 activity App 20040106547 - Larsen, Bjarne Due ; et al. | 2004-06-03 |
| Compositions and methods for modulating connexin hemichannels App 20040092429 - Jensen, Peter Holme ; et al. | 2004-05-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 